A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detalles Bibliográficos
Autor principal: Islam, Nahidul
Otros Autores: Talukder, Mesbah
Formato: Tesis
Lenguaje:English
Publicado: Brac University 2023
Materias:
Psoriasis
Biologics
FAERS
Interleukin inhibitors
Alopecia
Pharmacovigilance
Acceso en línea:http://hdl.handle.net/10361/22025

Internet

http://hdl.handle.net/10361/22025

Ejemplares similares